<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>690</id><JournalTitle>ANGIOTENSIN CONVERTING ENZYME IN EXPERIMENTAL  PREECLAMPSIA IN RATS</JournalTitle><Abstract>Preeclampsia (PE) is a life-threatening disorder of late pregnancy characterized by  hypertension and proteinuria, as 
well as renal and placental morphologic abnormalities.  Dysregulation of renin angiotensin system (RAS) has been considered 
to  contribute  to  the  disorder;  however  the  pathogenic  mechanisms  of  PE  remain  largely  undefined.     Using  an  experimental 
model  of  preeclampsia  resulting  from  inhibition  of  nitric  oxide  synthesis  with  L-NAME  administered  to  pregnant  rats,  we 
assessed some of the components of the renin angiotensin system.  In pregnant rats L-NAME treatment reduced fetuses mean 
weight, while did not change their number.   L-NAME increased mean arterial pressure and produced proteinuria, and this was 
associated with a significant decrease of plasma angiotensin converting enzyme activity, plasma renin levels and amniotic flu id 
aldosterone levels. These findings suggest that experimental preeclampsia is characterized by suppression of circulating reni n 
angiotensin system which could be responsible for imbalance between the vasoconstrictor and vasodilator systems, as well as 
some of the signs of preeclampsia similar to that in hypertensive pregnant women</Abstract><Email>astern88@gmail.com</Email><articletype>Research</articletype><volume>6</volume><issue>11</issue><year>2015</year><keyword>Preeclampsia,Angiotensin,Aldosterone,Angiotensin Converting Enzyme</keyword><AUTHORS>Camacho Elsa,Israel Anita</AUTHORS><afflication>Laboratory of Neuropeptides. School of Pharmacy. Universidad Central de Venezuela. Caracas, Venezuela,Laboratory of Neuropeptides. School of Pharmacy. Universidad Central de Venezuela. Caracas, Venezuela</afflication></Article></Articles>